SCHEMBL3833882

SCHEMBL3833882

CC1(c2cccc(Cl)c2)NC(=O)NC1c1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.40
SLC6A2 P23975 5/20 0.38
SLC6A3 Q01959 5/20 0.38
MDM2 Q00987 4/20 0.38
CHRNA1 P02708 3/20 0.38
CHRNG P07510 3/20 0.38
CHRNB1 P11230 3/20 0.38
CHRNB2 P17787 3/20 0.38
CHRNB4 P30926 3/20 0.38
CHRNA3 P32297 3/20 0.38
CHRNA4 P43681 3/20 0.38
CHRND Q07001 3/20 0.38
TP53 P04637 3/20 0.38
SLC6A4 P31645 2/20 0.38
HCAR3 P49019 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
P2RX7 Q99572 2/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3833886 1.00 HTT (0.40) HTTSLC6A2SLC6A3MDM2CHRNA1
SCHEMBL13567955 0.84 CHRNA1 (0.38) HTTSLC6A2SLC6A3MDM2CHRNA1
SCHEMBL13567957 0.84 CHRNA1 (0.38) HTTSLC6A2SLC6A3MDM2CHRNA1
SCHEMBL3833604 0.81 HTR6 (0.35) SLC6A2SLC6A3SLC6A4ALDH1A1TSHR
SCHEMBL3833602 0.81 HTR6 (0.35) SLC6A2SLC6A3SLC6A4ALDH1A1TSHR
SCHEMBL3833981 0.80 CNR1 (0.41) MDM2ALDH1A1TSHRMAPTMEN1
SCHEMBL3833984 0.80 CNR1 (0.41) MDM2ALDH1A1TSHRMAPTMEN1
SCHEMBL3833467 0.78 MDM2 (0.39) HTTSLC6A2SLC6A3MDM2CHRNA1
SCHEMBL3833471 0.78 MDM2 (0.39) HTTSLC6A2SLC6A3MDM2CHRNA1
SCHEMBL3834266 0.74 KCNQ3 (0.35) MDM2CHRNA1CHRNGCHRNB1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
EP-2103619-A1 IMIDAZOTHIAZOLE DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 HTT 3056/4885SLC6A2 4884/4885SLC6A3 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.